VEA
VYGR icon

Virtus ETF Advisers’s Voyager Therapeutics VYGR Stock Holding History

Virtus ETF Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,676
Closed -$83.4K – 500
2025
Q1 		$83.4K Buy
+24,676
New +$115K 0.05% 311
2021
Q2 		– Sell
-35,712
Closed -$168K – 403
2021
Q1 		$168K Buy
35,712
+633
+2% +$4.32K 0.07% 343
2020
Q4 		$251K Buy
35,079
+9,668
+38% +$92.9K 0.1% 313
2020
Q3 		$271K Sell
25,411
-3,463
-12% -$40.6K 0.14% 247
2020
Q2 		$364K Buy
28,874
+2,166
+8% +$25.2K 0.17% 248
2020
Q1 		$244K Sell
26,708
-3,900
-13% -$44.8K 0.1% 256
2019
Q4 		$427K Buy
30,608
+20,178
+193% +$293K 0.07% 237
2019
Q3 		$180K Sell
10,430
-581
-5% -$12.2K 0.04% 265
2019
Q2 		$300K Sell
11,011
-14,640
-57% -$335K 0.06% 214
2019
Q1 		$491K Sell
25,651
-3,556
-12% -$46.3K 1.04% 30
2018
Q4 		$275K Buy
29,207
+7,338
+34% +$94.2K 0.05% 139
2018
Q3 		$414K Sell
21,869
-15,633
-42% -$300K 0.04% 154
2018
Q2 		$733K Sell
37,502
-15,905
-30% -$314K 0.65% 81
2018
Q1 		$1M Buy
53,407
+29,821
+126% +$645K 0.87% 40
2017
Q4 		$392K Buy
+23,586
New +$404K 0.49% 58

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus ETF Advisers's VYGR Position: Q2 2025 in Review

Virtus ETF Advisers sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 24,676 shares — an estimated $83.4K sold.

Virtus ETF Advisers first reported a position in VYGR in Q4 2017 and held it in 15 quarters. The position peaked at $1M in Q1 2018. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.

  • Virtus ETF Advisers reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 24,676 Voyager Therapeutics shares in Q2 2025, an estimated $83.4K.
  • Virtus ETF Advisers first reported a position in Voyager Therapeutics in Q4 2017 and held it in 15 quarters.
  • Virtus ETF Advisers's Voyager Therapeutics position peaked at $1M in Q1 2018.
  • 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.

Based on Virtus ETF Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.